[drugawareness] ABC Tonight in Washington, DC to Discuss Daniel Troy

[Guest guest]

atracyphd2

Thu, 4 Nov 2004 11:34:01 EST

Subject:[drugawareness] ABC Tonight in Washington, DC to Discuss

Daniel Troy

 

Get unlimited calls to

 

U.S./Canada

My Groups | drugawareness Main Page

 

Daniel Troy is George Bush's Chief Council to the FDA. The ABC station

WJLA

in Washington, DC will be airing a story on Daniel Troy's misuse of

his office

this evening. It can be viewed online anytime after 7:00 PM Eastern Time

tonight at www.wjla.com .

 

(It may also prove interesting to note that the journalist who put

this all

together has confirmed that Daniel Troy has a brother named Tevi Troy

who is a

special assistant to president Bush and a friend and former colleague

of John

Ashcroft.)

 

Following are several articles on Daniel Troy that you may find very

interesting on who this man is and what he has been doing.

 

 

Ann Blake Tracy, Ph.D.,

Executive Director, International Coalition For Drug Awareness

Author: Prozac: Panacea or Pandora? - Our Serotonin Nightmare

& audio tape on safe withdrawal: " Help! I Can't Get

Off My Antidepressant! "

 

Order Number: 800-280-0730

Website: www.drugawareness.org

 

 

Daniel Troy -- George Bush's Chief Council To The FDA.

 

http://www.fda.gov/oc/orgcharts/occ.pdf

http://www.fda.gov/bbs/topics/calendar/2004/calendar249.html

 

http://www.environmentalobservatory.org/News/News.cfm?news_ID=2232

 

Like many other Bush appointees , Troy is now overseeing an industry

which

he used to represent.

 

The Boston Globe reports, " During the Clinton years, Troy was best

known for

suing the FDA.

 

http://www.drugawareness.org/Archives/4thQtr_2002/record0001.html

 

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

 

US Newswire: " After Bush took office, the number of enforcement actions

against misleading and false drug ads dropped significantly. In 2003

alone the

number of enforcement actions by the FDA was 75 percent lower than the

average in

the last two years of the Clinton Administration. These ads do not

disclose

all of the information that consumers deserve, and drive up the costs of

prescription drugs. Kerry and Edwards will end this waste by directing

the FDA to

crack down on misleading drug ad " s.

 

http://www.pharmacytimes.com/newsfeed.cfm?id=17580

 

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

 

Troy's Drug Industry Ploy

 

http://www.americanprogress.org/site/pp.asp?c=biJRJ8OVF & b=117321#2

 

A sworn affidavit filed in a Texas court case against Pfizer Inc. reveals

President Bush's top appointee at the Food and Drug Administration (FDA)

counseled pharmaceutical industry insiders on how to escape oversight

from his own ag

ency. FDA Chief Counsel Daniel Troy, a former drug lobbyist best known for

preventing the FDA from regulating big tobacco,

 

http://www.drugawareness.org/Archives/4thQtr_2002/record0001.html

 

headed a " roundtable discussion " in December 2003 with pharmaceutical

firms

and their defense lawyers. According to the affidavit, at the meetings

he " made

it abundantly clear that the FDA would exercise its intervention powers to

protect [drug industry] defendants from liability in state and federal

courts

throughout the nation. " Troy advised conference attendees, remarkably,

to invest

in research that would prove liability issues were keeping " good

products off

the shelf, " even while admitting the FDA currently had " no good

evidence " to

support such a claim. " You guys really shoot yourself in the foot by not

funding research to this effect, " he said. " I'll even take anecdotal

evidence and

stories if you have them. " Rep. Maurice Hinchey

 

http://www.house.gov/hinchey/

 

(D-NY) today will hold a Capitol Hill press conference with families

who have

been affected by Troy and the Bush administration's intervention on

behalf of

the drug industry.

 

TROY TOUTS LIMITED INFORMATION:

 

http://www.fda.gov/opacom/morechoices/mission.html

 

According to the sworn affidavit, Troy told the drug industry

conference it

was the FDA's goal to " control the flow of risk info regarding these

[drug and

medical device] products " to the public. This directly contradicts the

FDA's

mission: to help " the public get the accurate, science-based

information they

need to use medicines and foods to improve their health. " The

affidavit states

Troy made " no mention...of the FDA's real mandate, which is to regulate

manufacturers on behalf of consumers. " Instead, despite heading an

agency meant to

protect consumers,

 

http://www.kansascity.com/mld/kansascity/news/breaking_news/6822315.htm

 

Troy promoted the Bush administration's tort reform agenda to the

industry's

representatives, making " numerous derogatory remarks about plaintiffs,

'runaway juries,' and even " calling some attorneys representing

plaintiffs against

drug companies " bounty hunters. "

 

A TROY IN THE HENHOUSE:

 

http://www.environmentalobservatory.org/News/News.cfm?news_ID=2232

 

Like many other Bush appointees, Troy is now overseeing an industry

which he

used to represent. The Boston Globe reports, " During the Clinton

years, Troy

was best known for suing the FDA

 

http://www.drugawareness.org/Archives/4thQtr_2002/record0001.html

 

It was Troy who worked for the tobacco industry on the landmark

Supreme Court

case that prevented the agency from regulating tobacco. And he fought for

years to allow pharmaceutical companies to promote drugs for

unapproved uses. "

Now, as FDA counsel, Troy has made " unprecedented offer to drug

companies...likely to protect their profits and potentially hurt consumers

http://www.environmentalobservatory.org/News/News.cfm?news_ID=2232

" Since arriving at the FDA in 2001, " Troy's most aggressive efforts have

come on behalf of the pharmaceutical industry, " including the

unprecedented

intervention in select court cases on behalf of defendants, and the

loosening of

off-label rules which health advocates say could " 'deal a body blow'

to the

government's ability to defend the public from unproven and unsafe

treatments. "

TROY TAKES STAND FOR PHARMACEUTICAL GIANTS:

http://courses.che.umn.edu/02fscn11021s/general_food_safety/Ephedra/web

pages/USNew3-03DanielTroy.html

Troy's pro-industry stance goes way beyond words: the former industry

representative has engaged in an " open-door policy " with industry.

Early in his

tenure, he " held at least 50 meetings with representatives from the

industries FDA

regulates. " Journalists have requested records of those meetings, but were

" informed by Troy's office that there are 'no minutes, no memos, no

nothing.' "

In addition, " Troy's office, which dispatches warning letters to drug

companies

about potentially false advertising, has cut the rate by which the FDA

issues

those warnings by two-thirds in the past year. " Such letters used to

be sent

out by a branch within FDA, but Troy, has " arranged for all warnings to go

through his office

http://www.drugawareness.org/Archives/4thQtr_2002/record0001.html

TROY'S PFIZER CONNECTION: When the pharmaceutical giant Pfizer faced a

lawsuit in 2002 alleging the company's top selling antidepressant,

Zoloft, had

caused a patient to commit suicide, the drug company turned to its old

friend

Daniel Troy for help: The Boston Globe reported, " Troy was quite

familiar with the

company, having served as a Pfizer attorney in legal combat with the

FDA until

just months before he joined the agency last year

http://www.drugawareness.org/Archives/4thQtr_2002/record0001.html

Shortly after the one-year federal restriction on action involving his

former clients expired, Troy filed a government brief that backed up

Pfizer's

case. " When FDA was asked by the House Appropriations Committee about

Troy's

connection to Pfizer, the administration claimed he worked less than

80 hours per

year for the drug company. They did not say that, according to Troy's

financial

disclosure form, Pfizer had paid Troy's firm nearly $360,000 for services

" provided directly by " Troy in less than six months.

TROY'S FDA - A NEW FRIEND FOR THE DRUG INDUSTRY: Under Troy's

leadership, the

FDA's oversight role in the drug industry has changed dramatically. Since

President Bush took office, the FDA or Department of Justice has

intervened in at

least four major cases on behalf of pharmaceutical company defendants,

each

time claiming the FDA's own judgment would " implicitly preempt " any ruling

against the industry. Each time, FDA statements submitted to the

courts have

sought to limit information available to consumers about potentially

dangerous

drugs. One DOJ " Statement of Interest " argued against requiring the

manufacturer

of Paxil to remove from its advertisements the statement the drug was

" non-habit forming, " even though testimony indicated users experienced

traumatic

withdrawal symptoms.